These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 23946416)

  • 1. Elevated occipital β-amyloid deposition is associated with widespread cognitive impairment in logopenic progressive aphasia.
    Whitwell JL; Lowe VJ; Duffy JR; Strand EA; Machulda MM; Kantarci K; Wille SM; Senjem ML; Murphy MC; Gunter JL; Jack CR; Josephs KA
    J Neurol Neurosurg Psychiatry; 2013 Dec; 84(12):1357-64. PubMed ID: 23946416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progranulin-associated PiB-negative logopenic primary progressive aphasia.
    Josephs KA; Duffy JR; Strand EA; Machulda MM; Vemuri P; Senjem ML; Perkerson RB; Baker MC; Lowe V; Jack CR; Rademakers R; Whitwell JL
    J Neurol; 2014 Mar; 261(3):604-14. PubMed ID: 24449064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Varying Degrees of Temporoparietal Hypometabolism on FDG-PET Reveal Amyloid-Positive Logopenic Primary Progressive Aphasia is not a Homogeneous Clinical Entity.
    Krishnan K; Machulda MM; Whitwell JL; Butts AM; Duffy JR; Strand EA; Senjem ML; Spychalla AJ; Jack CR; Lowe VJ; Josephs KA
    J Alzheimers Dis; 2017; 55(3):1019-1029. PubMed ID: 27802232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of
    La Joie R; Visani AV; Lesman-Segev OH; Baker SL; Edwards L; Iaccarino L; Soleimani-Meigooni DN; Mellinger T; Janabi M; Miller ZA; Perry DC; Pham J; Strom A; Gorno-Tempini ML; Rosen HJ; Miller BL; Jagust WJ; Rabinovici GD
    Neurology; 2021 Feb; 96(5):e650-e661. PubMed ID: 33262228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and neuroimaging biomarkers of amyloid-negative logopenic primary progressive aphasia.
    Whitwell JL; Duffy JR; Strand EA; Machulda MM; Senjem ML; Schwarz CG; Reid R; Baker MC; Perkerson RB; Lowe VJ; Rademakers R; Jack CR; Josephs KA
    Brain Lang; 2015 Mar; 142():45-53. PubMed ID: 25658633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology.
    Laforce R; Tosun D; Ghosh P; Lehmann M; Madison CM; Weiner MW; Miller BL; Jagust WJ; Rabinovici GD
    Neuroimage Clin; 2014; 4():508-16. PubMed ID: 24818077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.
    Ossenkoppele R; Schonhaut DR; Schöll M; Lockhart SN; Ayakta N; Baker SL; O'Neil JP; Janabi M; Lazaris A; Cantwell A; Vogel J; Santos M; Miller ZA; Bettcher BM; Vossel KA; Kramer JH; Gorno-Tempini ML; Miller BL; Jagust WJ; Rabinovici GD
    Brain; 2016 May; 139(Pt 5):1551-67. PubMed ID: 26962052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease.
    Lehmann M; Ghosh PM; Madison C; Laforce R; Corbetta-Rastelli C; Weiner MW; Greicius MD; Seeley WW; Gorno-Tempini ML; Rosen HJ; Miller BL; Jagust WJ; Rabinovici GD
    Brain; 2013 Mar; 136(Pt 3):844-58. PubMed ID: 23358601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbleeds in the logopenic variant of primary progressive aphasia.
    Whitwell JL; Jack CR; Duffy JR; Strand EA; Gunter JL; Senjem ML; Murphy MC; Kantarci K; Machulda MM; Lowe VJ; Josephs KA
    Alzheimers Dement; 2014 Jan; 10(1):62-6. PubMed ID: 23562427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia.
    Rabinovici GD; Jagust WJ; Furst AJ; Ogar JM; Racine CA; Mormino EC; O'Neil JP; Lal RA; Dronkers NF; Miller BL; Gorno-Tempini ML
    Ann Neurol; 2008 Oct; 64(4):388-401. PubMed ID: 18991338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aphasia with left occipitotemporal hypometabolism: a novel presentation of posterior cortical atrophy?
    Wicklund MR; Duffy JR; Strand EA; Whitwell JL; Machulda MM; Josephs KA
    J Clin Neurosci; 2013 Sep; 20(9):1237-40. PubMed ID: 23850398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of Neuropsychological Dysfunction and Cortical Volume Changes in Logopenic Aphasia.
    Owens TE; Machulda MM; Duffy JR; Strand EA; Clark HM; Boland S; Martin PR; Lowe VJ; Jack CR; Whitwell JL; Josephs KA
    J Alzheimers Dis; 2018; 66(3):1015-1025. PubMed ID: 30372673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.
    Ossenkoppele R; Zwan MD; Tolboom N; van Assema DM; Adriaanse SF; Kloet RW; Boellaard R; Windhorst AD; Barkhof F; Lammertsma AA; Scheltens P; van der Flier WM; van Berckel BN
    Brain; 2012 Jul; 135(Pt 7):2115-25. PubMed ID: 22556189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visual cognition in non-amnestic Alzheimer's disease: Relations to tau, amyloid, and cortical atrophy.
    Putcha D; Brickhouse M; Touroutoglou A; Collins JA; Quimby M; Wong B; Eldaief M; Schultz A; El Fakhri G; Johnson K; Dickerson BC; McGinnis SM
    Neuroimage Clin; 2019; 23():101889. PubMed ID: 31200149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterizing White Matter Tract Degeneration in Syndromic Variants of Alzheimer's Disease: A Diffusion Tensor Imaging Study.
    Madhavan A; Schwarz CG; Duffy JR; Strand EA; Machulda MM; Drubach DA; Kantarci K; Przybelski SA; Reid RI; Senjem ML; Gunter JL; Apostolova LG; Lowe VJ; Petersen RC; Jack CR; Josephs KA; Whitwell JL
    J Alzheimers Dis; 2016; 49(3):633-43. PubMed ID: 26484918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of an atypical variant of logopenic progressive aphasia.
    Machulda MM; Whitwell JL; Duffy JR; Strand EA; Dean PM; Senjem ML; Jack CR; Josephs KA
    Brain Lang; 2013 Nov; 127(2):139-44. PubMed ID: 23566690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDG PET and MRI in logopenic primary progressive aphasia versus dementia of the Alzheimer's type.
    Madhavan A; Whitwell JL; Weigand SD; Duffy JR; Strand EA; Machulda MM; Tosakulwong N; Senjem ML; Gunter JL; Lowe VJ; Petersen RC; Jack CR; Josephs KA
    PLoS One; 2013; 8(4):e62471. PubMed ID: 23626825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, Neuropsychological, and Neuroimaging Characteristics of Amyloid- positive vs. Amyloid-negative Patients with Clinically Diagnosed Alzheimer's Disease and Amnestic Mild Cognitive Impairment.
    Wang Y; Lou F; Li Y; Liu F; Wang Y; Cai L; Gordon ML; Zhang Y; Zhang N
    Curr Alzheimer Res; 2021; 18(6):523-532. PubMed ID: 34598664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asymmetries of amyloid-β burden and neuronal dysfunction are positively correlated in Alzheimer's disease.
    Frings L; Hellwig S; Spehl TS; Bormann T; Buchert R; Vach W; Minkova L; Heimbach B; Klöppel S; Meyer PT
    Brain; 2015 Oct; 138(Pt 10):3089-99. PubMed ID: 26280595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative assessment of grammar in amyloid-negative logopenic aphasia.
    Tetzloff KA; Whitwell JL; Utianski RL; Duffy JR; Clark HM; Machulda MM; Strand EA; Josephs KA
    Brain Lang; 2018 Nov; 186():26-31. PubMed ID: 30205287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.